Also trades as: JMDMF (OTC) · $vol 0M
7600.T JPX
Japan Medical Dynamic Marketing, Inc.
1W: -9.7%
1M: -15.9%
3M: -30.3%
YTD: +23.3%
1Y: +12.3%
3Y: -34.6%
5Y: -70.2%
¥613.00 ($3.88)
-2.00 (-0.33%)
Weekly Expected Move ±7.7%
¥519
¥566
¥613
¥660
¥707
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$1.0B
-50.3% ▼
5Y CAGR: -17.5%
Capital Expenditures
$1.6B
+14.0% ▲
5Y CAGR: -2.8%
Free Cash Flow
-$504M
-266.7% ▼
Dividends Paid
$371M
-7.9% ▼
Buybacks
$11M
+85.3% ▲
Net Change in Cash
$861M
+278.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $2.0B | $2.7B | $1.8B | $1.6B | -$462M |
| Depreciation & Amort. | $1.4B | $1.4B | $1.5B | $1.6B | $1.7B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$494M | -$430M | -$1.0B | -$302M | -$1.2B |
| Other Non-Cash Items | -$329M | -$629M | -$123M | -$825M | $994M |
| Operating Cash Flow | $2.6B | $3.1B | $2.2B | $2.1B | $1.0B |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.4B | -$1.6B | -$1.3B | -$1.8B | -$1.7B |
| Acquisitions (Net) | $26M | -$166M | -$99M | $0 | $0 |
| Investment Purchases | $0 | $0 | -$67M | $0 | $0 |
| Investment Sales | $0 | $0 | -$93M | $0 | $0 |
| Other Investing | $926K | $820K | $93M | -$2M | -$345K |
| Investing Cash Flow | -$1.3B | -$1.8B | -$1.5B | -$1.8B | -$1.7B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1.0B | -$997M | -$73M | -$424M | $1.9B |
| Stock Repurchased | -$279K | -$401K | -$91M | -$73M | -$11M |
| Dividends Paid | -$264M | -$290M | -$317M | -$344M | -$371M |
| Other Financing | -$1K | -$1K | -$34M | -$2K | -$3K |
| Financing Cash Flow | -$1.3B | -$1.3B | -$515M | -$841M | $1.5B |
| Net Change in Cash | -$47M | $125M | $214M | -$483M | $861M |
| Cash End of Period | $2.5B | $2.6B | $2.8B | $2.3B | $3.2B |
| Free Cash Flow | $1.2B | $1.5B | $871M | $302M | -$504M |